{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:17:02Z","timestamp":1787170622479,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/jac\/dkw591","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T07:41:20Z","timestamp":1486194080000},"page":"1272-1274","source":"Crossref","is-referenced-by-count":43,"title":["Antimicrobials and QT prolongation"],"prefix":"10.1093","volume":"72","author":[{"given":"Jay W.","family":"Mason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"key\n\t\t\t\t20170421073518_dkw591-B1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkw428","article-title":"Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects","volume":"72","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2125.2005.02395.x","article-title":"Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women","volume":"60","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B3","article-title":"A thorough QT study to define the ECG effects of cethromycin (CER) using a clinical and a supratherapeutic dose compared to placebo and moxifloxacin (MFX) in healthy subjects (CL07-001)","year":"2008","journal-title":"IDSA Abstracts Online"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B4","author":"EMEA","year":"2001"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2006.09.035","article-title":"In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation","volume":"553","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2014.12.037","article-title":"Comparison of formulas for calculation of the corrected QT interval in infants and young children","volume":"166","year":"2015","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B7","doi-asserted-by":"crossref","first-page":"e003264","DOI":"10.1161\/JAHA.116.003264","article-title":"Which QT correction formulae to use for QT monitoring?","volume":"5","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/bph.12575","article-title":"Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channels","volume":"171","year":"2014","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1755-5922.12054","article-title":"Antibiotic-induced cardiac arrhythmias","volume":"32","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B10","first-page":"U666.","article-title":"A case of QT-interval prolongation precipitated by azithromycin","volume":"116","year":"2003","journal-title":"N Z Med J"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B11","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1460-9592.2001.01572.x","article-title":"QT prolongation associated with azithromycin\/amiodarone combination","volume":"24","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B12","year":"2013"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2014.4304","article-title":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B15","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.09.029","article-title":"The role of macrolide antibiotics in increasing cardiovascular risk","volume":"66","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejim.2015.09.009","article-title":"Association of macrolides with overall mortality and cardiac death among patients with various infections: a meta-analysis","volume":"28","year":"2016","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B18","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1155\/2013\/652512","article-title":"Macrolide use in the treatment of critically ill patients with pneumonia: incidence, correlates, timing and outcomes","volume":"24","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jhm.2448","article-title":"Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center","volume":"11","year":"2016","journal-title":"J Hosp Med"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B20","author":"EMEA","year":"1997"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B21","author":"FDA","year":"2005"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2008.03319.x","article-title":"Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period","volume":"67","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCOUTCOMES.113.000651","article-title":"Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients","volume":"7","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B24","doi-asserted-by":"crossref","first-page":"666.","DOI":"10.1016\/0002-9149(86)90306-1","article-title":"QT prolongation and recurrent \u2018torsades de pointes\u2019 during erythromycin lactobionate infusion","volume":"58","year":"1986","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1177\/0091270009356298","article-title":"Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies","volume":"50","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B26","first-page":"795.","article-title":"Chloroquine and QTc interval","volume":"25","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","article-title":"Pentamidine-induced long QT syndrome and block of hERG trafficking","volume":"312","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B28","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1540-8167.2005.00299.x","article-title":"Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug","volume":"16","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jac\/dks404","article-title":"Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(05)70936-3","article-title":"Blockade of HERG channels by HIV protease inhibitors","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bjp.0706678","article-title":"Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin","volume":"147","year":"2006","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s002280000229","article-title":"The effects of grapefruit juice on the pharmacokinetics of erythromycin","volume":"56","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.1552-4604.1993.tb03920.x","article-title":"Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics","volume":"33","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.bjp.0705335","article-title":"Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652","volume":"139","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170421073518_dkw591-B35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2010.10.010","article-title":"Fluconazole inhibits hERG K+ channel by direct block and disruption of protein trafficking","volume":"650","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 3","key":"key\n\t\t\t\t20170421073518_dkw591-B36","first-page":"S327","article-title":"Drug interactions with fluconazole","volume":"12","year":"1990","journal-title":"Rev Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/5\/1272\/13703494\/dkw591.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:18:37Z","timestamp":1719029917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,4]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw591","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,4]]}}}